End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 MYR | +0.85% | +1.72% | -6.35% |
Business Summary
Sales per Business
MYR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 697 | 100.0 % | 705 | 100.0 % | +1.15% |
Sales per region
MYR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Malaysia
100.0
%
| 697 | 100.0 % | 705 | 100.0 % | +1.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 17-12-27 | |
Wu Kong Chek
DFI | Director of Finance/CFO | 59 | 00-08-06 |
Investor Relations Contact | - | - | |
Comptroller/Controller/Auditor | 40 | 17-12-27 | |
Corporate Officer/Principal | 52 | 16-09-04 | |
Corporate Officer/Principal | 55 | 97-12-31 | |
General Counsel | 57 | 17-12-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 16-04-04 | |
Chief Executive Officer | 60 | 17-12-27 | |
Razalee bin Amin
BRD | Director/Board Member | 71 | 16-05-31 |
Director/Board Member | 63 | 23-05-31 | |
Director/Board Member | 67 | 18-03-07 | |
Director/Board Member | 65 | 16-08-31 | |
Director/Board Member | 71 | 17-12-27 | |
Director/Board Member | 69 | 16-11-15 | |
Director/Board Member | 74 | 19-09-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 961,942,000 | 435,298,973 ( 45.25 %) | 0 | 45.25 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PANGEN BIOTECH INC. 7.55% | 806,450 | 7.55% | 3,749,952 $ |
Company contact information
Duopharma Biotech Bhd.
Lot 2599, Jalan Seruling 59 Kawasan 3
41200, Klang
+
http://www.duopharmabiotech.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.35% | 238M | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- DPHARMA Stock
- Company Duopharma Biotech